GNLX- Genelux Corporation

Insider activity in GNLX over the last quarter tilts toward selling: insiders offloaded a net 58,732 shares worth roughly $159K.

Classified under Biotechnology (Health Care sector), GNLX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Zindrick Thomas	1.23M	$3.27M	-
Dir	Thomas John	501.2K	-	-
Other	Cappello Joseph	318.5K	$872.9K	-
CFO	Pulisic Matthew	278.9K	-	-
Other	Litten Jason	275.0K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 11, 2026	Smalling Ralph54	Head Of Regulatory	Sell	270	$2.98	$804.49	-0.4%	-	-
May 11, 2026	Yu Yong77	Chief Scientific Officer	Sell	605	$2.97	$1,798.42	-0.4%	-	-
May 11, 2026	Cappello Joseph47	Chief Technical Officer	Sell	605	$2.97	$1,799.39	-0.4%	-	-
Mar 25, 2026	Smalling Ralph54	Head Of Regulatory	Sell	585	$2.46	$1,437.30	-0.9%	+10.2%	-
Mar 24, 2026	Yu Yong77	SVP, Clinical Development	Sell	906	$2.42	$2,192.52	-0.6%	+22.5%	-
Mar 24, 2026	Cappello Joseph47	Chief Technical Officer	Sell	906	$2.42	$2,192.52	-0.6%	+22.5%	-
Mar 24, 2026	Zindrick Thomas	President And CEO	Sell	3,582	$2.42	$8,668.44	-0.7%	+22.5%	-
Mar 2, 2026	Thomas John77	Director	Sell	10,000	$2.90	$28,957.00	-2.0%	-	-
Dec 5, 2025	Smalling Ralph54	Head Of Regulatory	Sell	2,332	$3.75	$8,740.38	-3.3%	-42.1%	-
Dec 1, 2025	Thomas John77	Director	Sell	10,000	$5.00	$50,008.00	-2.0%	-41.2%	-